Therapeutic Challenges in the Use of Chemotherapy and Cyclin-Dependent Kinase 4/6 Inhibitors in a Patient With Charcot-Marie-Tooth Disease and Breast Cancer. This evidence concerns the gene CDK4 and Charcot-Marie-Tooth disease.